DHFB
BIIB icon

Dixon Hubard Feinour & Brown’s Biogen BIIB Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$375K Sell
1,841
-851
-32% -$174K 0.04% 217
2022
Q1 		$567K Sell
2,692
-600
-18% -$130K 0.06% 202
2021
Q4 		$790K Buy
+3,292
New +$846K 0.08% 175

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Dixon Hubard Feinour & Brown's BIIB Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its Biogen (BIIB) stake by 32% in Q2 2022, selling an estimated $174K and leaving 1,841 shares worth $375K. The position accounts for 0.04% of the portfolio, ranked #217.

Dixon Hubard Feinour & Brown first reported a position in BIIB in Q4 2021 and has held it in 3 quarters since. The position peaked at $790K in Q4 2021. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 1,841 shares of Biogen worth $375K as of Q2 2022.
  • Dixon Hubard Feinour & Brown sold 851 Biogen shares in Q2 2022, an estimated $174K.
  • Biogen made up 0.04% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #217 holding.
  • Dixon Hubard Feinour & Brown first reported a position in Biogen in Q4 2021 and has held it in 3 quarters since.
  • Dixon Hubard Feinour & Brown's Biogen position peaked at $790K in Q4 2021.
  • 928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.